Biocapital Advisors Lp Paradigm serves as Executive at Olema Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Biocapital Advisors Lp Paradigm has executed 2 insider transactions totaling $35.8M, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 1, 2024 involved selling 1,870,499 shares valued at $27.9M.
Biocapital Advisors Lp Paradigm currently holds 4,720,482 shares of Olema Pharmaceuticals, Inc. (OLMA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Biocapital Advisors Lp Paradigm has been a net seller of OLMA stock. They have purchased $0 and sold $35.8M worth of shares.
Biocapital Advisors Lp Paradigm's most recent insider trade was on Aug 1, 2024, when they sold 1,870,499 shares at $14.92 per share.
Get notified when new Form 4 filings are submitted
| $14.92 |
| Discretionary |